Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2101 to 2115 of 9127 results

  1. Autologous platelet-rich plasma (PRP) injection of the lumbar facet (zygapophyseal) joints, via the intra-articular or medial branch route, for lumbar facet joint pain

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  2. LATERA absorbable nasal implant for Nasal valve collapse causing nasal obstruction

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  3. Cryoablation for abdominal wall endometriosis

    Topic prioritisation

    HealthTech guidance
    Topic prioritisation

  4. Digital platforms to support preparation before and rehabilitation after primary elective hip or knee replacement surgery: early-use assessment: draft guidance

    We are listening to your views on this HealthTech guidance. Comments close 27 July 2026.

    In consultation

  5. Middle meningeal artery embolisation for non-acute subdural haematomas: interventional procedure consultation

    We are listening to your views on this HealthTech guidance. Comments close 27 July 2026.

    In consultation

  6. Self-directed automated audiometry for the diagnosis of hearing loss in adults (provisional title)

    In development Reference number: GID-HTG10909 Expected publication date: TBC

    HealthTech guidance
    Awaiting development

  7. Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer (MA review of TA781) [ID6287]: final draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 23 July 2026.

    Technology appraisal guidance
    In consultation

  8. Lecanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID4043]

    In development Reference number: GID-TA11220 Expected publication date: TBC

    Technology appraisal guidance
    In development

  9. Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]

    In development Reference number: GID-TA11221 Expected publication date: TBC

    Technology appraisal guidance
    In development

  10. Cabozantinib for treating advanced neuroendocrine tumours that have progressed after systemic treatment [ID6474]

    In development Reference number: GID-TA11613 Expected publication date: TBC

    Technology appraisal guidance
    In development

  11. Extravascular implantable cardioverter defibrillator insertion for preventing sudden cardiac death caused by ventricular arrhythmia

    In development Reference number: GID-HTG10882 Expected publication date:  08 April 2027

    HealthTech guidance
    In development

  12. Monofocal intraocular lenses for cataract surgery

    In development Reference number: GID-HTG10875 Expected publication date:  10 March 2027

    HealthTech guidance
    In development

  13. Inavolisib with pertuzumab–trastuzumab for maintenance treatment of PIK3CA-mutated HER2-positive advanced breast cancer after induction chemotherapy

    Awaiting development Reference number: GID-TA12441 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  14. Acalabrutinib with bendamustine and rituximab for untreated mantle cell lymphoma [ID6155]

    In development Reference number: GID-TA11091 Expected publication date:  04 June 2026

    Technology appraisal guidance
    In development

  15. CaRi-Heart for predicting cardiac risk in adults with suspected coronary artery disease (CAD)

    In development Reference number: GID-HTG10885 Expected publication date:  02 December 2026

    HealthTech guidance
    In development